FindTrial
Sign In

Clinical Research on the interventional Diagnosis and Treatment of Stable Coronary heart disease complicated with cerebrovascular stenosis

Research and Development of Key New Technologies in Clinical Medicine of "Cardio-Brain Co-treatment" in Yunnan Province Subproject "Clinical Key Technologies and Promotion and Application of cardio-brain Co-treatment Based on cardiac Interventional complex Surgery Platform" -"Clinical Research on the interventional Diagnosis and Treatment of Stable Coronary heart disease complicated with cerebrovascular stenosis"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091954
Enrollment
Unknown
Registered
2024-11-06
Start date
2023-07-03
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease, cerebrovascular disease

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Over 18 years old. 2. Patients admitted to the cardiovascular department of our hospital in accordance with the 2018 Chinese Guidelines for the Diagnosis and Treatment of Stable Coronary Heart Disease were proposed to undergo coronary angiography. Carotid artery ultrasound or head and carotid CT angiography were performed to indicate severe cerebrovascular stenosis, and the cerebrovascular disease department evaluated the patients with indications of cerebrovascular angiography. 3. Patients admitted to the Department of Cerebrovascular Disease of our hospital for elective cerebrovascular angiography were considered coronary heart disease and were evaluated by cardiovascular physicians in accordance with the 2018 Chinese Guidelines for the Diagnosis and Treatment of Stable Coronary Heart Disease.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction; 2. Acute cerebrovascular accident; 3. Abnormal renal function, creatinine > 177umol/L; 4. Severe Heart failure, New York Heart Association (NYHA) heart function rating III or higher. 5. Complex coronary lesions are expected to require IABP placement. 6. Patients with severe bleeding tendency or recent history of bleeding disease. 7. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Coronary stenosis rate;Cerebrovascular stenosis rate;—

Secondary

MeasureTime frame
fractional flow reserve;—

Countries

China

Contacts

Public ContactSun Lin

The Second Affiliated Hospital of Kunming Medical University

sunlinkm@sina.com+86 138 8843 9860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026